Home
Storia in 2 fonti
Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%
Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating in the in-vitro diagnostics and healthcare solutions segment, saw strong subscription on its first day. Proceeds will be used for working capital, debt repayment, and general corporate purposes.
- ·
thehindubusinessline.com
Q-Line Biotech to raise ₹214 cr via IPO on NSE Emerge
Q-Line Biotech plans to raise ₹214 crore through an IPO on NSE Emerge for working capital and loan repayment.
- ·
economictimes.indiatimes.com
Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%
Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating in the in-vitro diagnostics and…